It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CTLT’s FA Score shows that 1 FA rating(s) are green whileELAN’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CTLT’s TA Score shows that 4 TA indicator(s) are bullish while ELAN’s TA Score has 4 bullish TA indicator(s).
CTLT (@Pharmaceuticals: Other) experienced а -0.52% price change this week, while ELAN (@Pharmaceuticals: Other) price change was -0.64% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -5.07%. For the same industry, the average monthly price growth was -7.87%, and the average quarterly price growth was -11.90%.
CTLT is expected to report earnings on Feb 11, 2025.
ELAN is expected to report earnings on Feb 19, 2025.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
CTLT | ELAN | CTLT / ELAN | |
Capitalization | 10.2B | 7.87B | 130% |
EBITDA | -754M | -224M | 337% |
Gain YTD | 31.538 | -6.174 | -511% |
P/E Ratio | 208.33 | N/A | - |
Revenue | 4.1B | 4.42B | 93% |
Total Cash | 229M | 352M | 65% |
Total Debt | 5.01B | 5.77B | 87% |
CTLT | ELAN | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 62 | 10 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 94 Overvalued | 66 Overvalued | |
PROFIT vs RISK RATING 1..100 | 88 | 100 | |
SMR RATING 1..100 | 92 | 92 | |
PRICE GROWTH RATING 1..100 | 48 | 54 | |
P/E GROWTH RATING 1..100 | 2 | 69 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ELAN's Valuation (66) in the Agricultural Commodities Or Milling industry is in the same range as CTLT (94) in the Pharmaceuticals Other industry. This means that ELAN’s stock grew similarly to CTLT’s over the last 12 months.
CTLT's Profit vs Risk Rating (88) in the Pharmaceuticals Other industry is in the same range as ELAN (100) in the Agricultural Commodities Or Milling industry. This means that CTLT’s stock grew similarly to ELAN’s over the last 12 months.
CTLT's SMR Rating (92) in the Pharmaceuticals Other industry is in the same range as ELAN (92) in the Agricultural Commodities Or Milling industry. This means that CTLT’s stock grew similarly to ELAN’s over the last 12 months.
CTLT's Price Growth Rating (48) in the Pharmaceuticals Other industry is in the same range as ELAN (54) in the Agricultural Commodities Or Milling industry. This means that CTLT’s stock grew similarly to ELAN’s over the last 12 months.
CTLT's P/E Growth Rating (2) in the Pharmaceuticals Other industry is significantly better than the same rating for ELAN (69) in the Agricultural Commodities Or Milling industry. This means that CTLT’s stock grew significantly faster than ELAN’s over the last 12 months.
CTLT | ELAN | |
---|---|---|
RSI ODDS (%) | 3 days ago82% | 3 days ago76% |
Stochastic ODDS (%) | 3 days ago48% | 3 days ago89% |
Momentum ODDS (%) | 3 days ago70% | 3 days ago62% |
MACD ODDS (%) | 3 days ago59% | 3 days ago67% |
TrendWeek ODDS (%) | 3 days ago61% | 3 days ago74% |
TrendMonth ODDS (%) | 3 days ago65% | 3 days ago66% |
Advances ODDS (%) | N/A | 11 days ago65% |
Declines ODDS (%) | 4 days ago63% | 3 days ago73% |
BollingerBands ODDS (%) | 3 days ago71% | 3 days ago80% |
Aroon ODDS (%) | 3 days ago76% | 3 days ago77% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FSEC | 42.80 | 0.04 | +0.10% |
Fidelity Investment Grade Sec ETF | |||
ABEQ | 32.31 | -0.10 | -0.31% |
Absolute Select Value ETF | |||
JANZ | 35.23 | -0.36 | -1.00% |
TrueShares Structured Outcome JanuaryETF | |||
GDIV | 15.24 | -0.20 | -1.30% |
Harbor Dividend Growth Leaders ETF | |||
SCHG | 26.98 | -0.56 | -2.03% |
Schwab US Large-Cap Growth ETF™ |
A.I.dvisor tells us that CTLT and TXMD have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTLT and TXMD's prices will move in lockstep.
Ticker / NAME | Correlation To CTLT | 1D Price Change % | ||
---|---|---|---|---|
CTLT | 100% | +0.32% | ||
TXMD - CTLT | 28% Poorly correlated | -4.11% | ||
RGEDF - CTLT | 27% Poorly correlated | N/A | ||
ELAN - CTLT | 26% Poorly correlated | -0.43% | ||
ESPR - CTLT | 26% Poorly correlated | +0.95% | ||
ALVO - CTLT | 26% Poorly correlated | -2.82% | ||
More |
A.I.dvisor indicates that over the last year, ELAN has been loosely correlated with SNDL. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ELAN jumps, then SNDL could also see price increases.
Ticker / NAME | Correlation To ELAN | 1D Price Change % | ||
---|---|---|---|---|
ELAN | 100% | -0.43% | ||
SNDL - ELAN | 39% Loosely correlated | N/A | ||
TEVA - ELAN | 34% Loosely correlated | -1.91% | ||
ACET - ELAN | 33% Poorly correlated | -9.82% | ||
PCRX - ELAN | 32% Poorly correlated | +1.41% | ||
VTRS - ELAN | 31% Poorly correlated | +1.66% | ||
More |